AZN vs LLY

AstraZeneca PLC against Eli Lilly and Company — live side-by-side technical comparison.

Prices as of 2026-11-10T21:00:02+00:00 UTC · updates daily

Who leads right now

LLY leads 6 of the 6 windows we measure — over 1 month AZN is +17.3% and LLY +21.5%; over year to date AZN is +1.6% and LLY +33.3%. The AZN/LLY price ratio stands at 0.1304, below its 50-day average of 0.1371, and below the 200-day average of 0.1665. A ratio above its own average means AZN is gaining on LLY; on this reading the recent edge belongs to LLY.

AZN/LLY over the last year

AZN/LLY price ratio · dashed: its 50- and 200-day lines · ratio above its 50-day line = AZN gaining on LLY
0.12310.15750.19180.2261
Both rebased to 100 on 2025-11-10
100107.3128.9148AZNLLY
Ask
Compare AZN and LLY: which has been stronger over the last year, and where does each stand against its 200-day average? Ask the analyst about this pair →

Performance side by side

AZNLLY
Price$186.76 $1432.29
1 day -1.4% +1.4%lead
5 days +1.6% +1.6%lead
1 month +17.3% +21.5%lead
6 months +2.1% +51.0%lead
Year to date +1.6% +33.3%lead
1 year +6.7% +48.2%lead
2 years — —
52-week position 56% of range 97% of range
52-week range $153.41–$212.71 $850.51–$1453.00
vs 50-day average above $167.50 above $1224.51
vs 200-day average above $180.23 above $1103.22
RSI (14) 66 70
Market cap—$1.28T
Analyst target — $1453.40 (+1.5%)
Analysts—29
Consensus—Buy
Next earnings Oct 30, 2026 Oct 29, 2026

Where each one stands

AZN — AstraZeneca PLC

AZN trades at $186.76, above its 50-day average of $167.50, and above the 200-day at $180.23. It sits at 56% of its 52-week range ($153.41–$212.71); 14-day RSI is 66, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $187.86 (0.6% away) and the first support below is $183.01 (2.0% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.

LLY — Eli Lilly and Company

LLY trades at $1,432.29, above its 50-day average of $1,224.51, and above the 200-day at $1,103.22. It sits at 97% of its 52-week range ($850.51–$1,453.00); 14-day RSI is 70, in neutral territory; an average session moves it about 3.7%. For levels, the first level overhead is $1,450.00 (1.2% away) and the first support below is $1,400.00 (2.2% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

Which one moves harder

LLY is the more volatile of the two — an average session moves it 3.7% against 2.7% for AZN, so an identical position size carries roughly 1.4× the daily risk.

What would change the picture

The comparison turns on those levels: AZN clearing $187.86 or losing $183.01; LLY clearing $1,450.00 or losing $1,400.00. Until one of them gives way, the relative reading above stands.

Questions people ask about AZN vs LLY

Which is performing better right now, AZN or LLY?
Over the past month AZN is +17.3% and LLY is +21.5%, so LLY is ahead on that window. Year to date the figures are +1.6% for AZN and +33.3% for LLY.
Which has done better over the last year, AZN or LLY?
Over the last year AZN is +6.7% and LLY is +48.2%, so LLY is ahead on that window.
Is AZN or LLY more volatile?
LLY is the more volatile of the two — an average session moves it 3.7% against 2.7% for AZN, so an identical position size carries roughly 1.4× the daily risk.
What are the key levels for AZN and LLY?
AZN: resistance $187.86, support $183.01; LLY: resistance $1,450.00, support $1,400.00. Levels come from recent swing zones and round numbers, recomputed daily.
When do AZN and LLY report next?
AZN: Oct 30, 2026. LLY: Oct 29, 2026. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the AZN/LLY ratio mean?
It is simply AZN's price divided by LLY's — 0.1304 today. When the ratio rises, AZN is outperforming; when it falls, LLY is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

AZN →
AstraZeneca PLC
Full technical brief: trend, levels, chart, news
LLY →
Eli Lilly and Company
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs MerckLLY vs UNHLLY vs NVSLLY vs TMOAMGN vs LLYGILD vs LLY